The American Society for Clinical Pharmacology and Therapeutics (ASCPT) was founded in 1900, and consists of over 2,300 professionals whose primary interest is to advance the science and practice of clinical pharmacology and translational science for the therapeutic benefit of patients and society. ASCPT is the largest scientific and professional organization serving the disciplines of clinical pharmacology and translational science.
ASCPT focuses on improving the understanding and use of existing drug therapies and developing safer and more effective treatments for the future. Our memberships' unique combination of scientific and clinical expertise makes them especially qualified to understand the impact of disease on patients, the compelling need for effective drug therapy, and the efforts necessary to meet those needs. Such efforts include research, exchange of scientific information, and awareness of legislative requirements that affect drug development and regulation.
ASCPT’s influence and leadership drives the advancement of translational science, building on a foundation of clinical pharmacology and therapeutics.
The Society's strategic plan for 2020 through 2025 focuses on five goals of enhancing career growth, stimulating scientific advancements, expanding patient-focused engagement, diversifying learning experiences, and providing exceptional value.